V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20024862 | 20010559 | 1.78 | 66 | Neo-adjuvant (N) | 2016-05-10 | 2016-05-16 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20087816 | FEC + DOCETAXEL |
| 20024863 | 20010559 | 1.62 | 68.9 | Disease modification (D) | 2013-07-14 | 2013-07-15 | FEC 100 + DOCETAXEL | 2 | N | 20087816 | FEC + DOCETAXEL |
| 20024864 | 20010560 | 1.7 | 78 | Not known (9) | 2018-03-15 | 2018-03-15 | FEC 100 + DOCETAXEL | 02 | N | 20087829 | FEC + DOCETAXEL |
| 20024865 | 20071140 | 1.56 | 68.2 | Adjuvant (A) | 2015-11-25 | 2015-12-02 | FEC + DOCETAXEL | 2 | N | 20087831 | FEC + DOCETAXEL |
| 20024866 | 20010561 | 1.55 | 87.4 | Adjuvant (A) | 2013-09-23 | 2013-10-28 | FEC + DOCETAXEL | N | N | 20087833 | FEC + DOCETAXEL |
| 20024867 | 20010561 | null | 79.7 | Neo-adjuvant (N) | 2013-12-21 | 2014-01-08 | FEC 100 + DOCETAXEL | 02 | Y | 20087833 | FEC + DOCETAXEL |
| 20024868 | 20010561 | 1.67 | 72.7 | Curative (C) | 2013-09-10 | 2013-09-12 | FEC + DOCETAXEL | 02 | N | 20087833 | FEC + DOCETAXEL |
| 20024869 | 20010562 | null | 71.25 | Neo-adjuvant (N) | 2015-11-25 | 2015-12-16 | FEC + DOCETAXEL | 2 | N | 20087847 | FEC + DOCETAXEL |
| 20024870 | 20071142 | 1.55 | 101 | Adjuvant (A) | 2015-11-14 | 2015-11-14 | FEC + DOCETAXEL | 02 | N | 20087849 | FEC + DOCETAXEL |
| 20024871 | 20071142 | null | 67.6 | null | 2015-05-14 | 2015-05-28 | FEC 100 + DOCETAXEL | N | N | 20087849 | FEC + DOCETAXEL |
| 20024872 | 20010563 | 1.65 | 65 | Neo-adjuvant (N) | 2016-02-05 | 2016-02-07 | FEC + DOCETAXEL | N | null | 20087853 | FEC + DOCETAXEL |
| 20024873 | 20010563 | 1.59 | null | Adjuvant (A) | 2016-10-10 | 2016-10-25 | FEC + DOCETAXEL | N | N | 20087853 | FEC + DOCETAXEL |
| 20024874 | 20010564 | 1.69 | 61 | Adjuvant (A) | 2014-05-08 | 2014-05-08 | FEC + DOCETAXEL | N | N | 20087860 | FEC + DOCETAXEL |
| 20024875 | 20010564 | 1.65 | 75.1 | Adjuvant (A) | 2017-10-11 | 2017-10-18 | FEC 100 + DOCETAXEL | 02 | N | 20087860 | FEC + DOCETAXEL |
| 20024876 | 20010565 | 1.57 | 100.4 | Adjuvant (A) | 2017-08-10 | 2017-08-31 | FEC + DOCETAXEL | N | N | 20087870 | FEC + DOCETAXEL |
| 20024877 | 20010565 | null | null | Neo-adjuvant (N) | 2014-03-13 | 2014-03-19 | FEC 100 + DOCETAXEL | N | N | 20087870 | FEC + DOCETAXEL |
| 20024878 | 20010566 | 1.64 | 68 | Adjuvant (A) | 2017-09-18 | 2017-10-02 | FEC 100 + DOCETAXEL | N | N | 20087876 | FEC + DOCETAXEL |
| 20024879 | 20010566 | null | 4 | null | 2017-07-18 | 2017-08-06 | FEC + DOCETAXEL | N | null | 20087876 | FEC + DOCETAXEL |
| 20024880 | 20010567 | 1.61 | null | Adjuvant (A) | 2013-04-17 | 2013-04-17 | FEC + DOCETAXEL | N | N | 20087881 | FEC + DOCETAXEL |
| 20024881 | 20010567 | 1.71 | 63.4 | Neo-adjuvant (N) | 2013-10-23 | 2013-10-24 | FEC 100 + DOCETAXEL | 02 | N | 20087881 | FEC + DOCETAXEL |
| 20024882 | 20010568 | 1.64 | 63 | Curative (C) | 2014-06-11 | 2014-06-11 | FEC + DOCETAXEL | 02 | N | 20087903 | FEC + DOCETAXEL |
| 20024883 | 20010568 | null | 64.8 | Adjuvant (A) | 2013-11-10 | 2013-11-10 | FEC + DOCETAXEL | 02 | N | 20087903 | FEC + DOCETAXEL |
| 20024884 | 20010568 | null | null | null | 2015-01-12 | 2015-02-11 | FEC 100 + DOCETAXEL | N | N | 20087903 | FEC + DOCETAXEL |
| 20024885 | 20010569 | 1.61 | 77.4 | Adjuvant (A) | null | 2015-04-29 | FEC 100 + DOCETAXEL | N | N | 20087913 | FEC + DOCETAXEL |
| 20024886 | 20010569 | 1.74 | 73.75 | Adjuvant (A) | 2018-01-11 | 2018-01-25 | FEC + DOCETAXEL | N | N | 20087913 | FEC + DOCETAXEL |
| 20024887 | 20010569 | 1.57 | 83.8 | Adjuvant (A) | 2016-03-05 | 2016-03-11 | FEC + DOCETAXEL | 02 | N | 20087913 | FEC + DOCETAXEL |
| 20024888 | 20010570 | null | null | Adjuvant (A) | null | 2014-06-22 | FEC 100 + DOCETAXEL | null | null | 20087920 | FEC + DOCETAXEL |
| 20024889 | 20010571 | 1.53 | null | Adjuvant (A) | 2015-05-21 | 2015-06-06 | FEC + DOCETAXEL | N | N | 20087923 | FEC + DOCETAXEL |
| 20024890 | 20010571 | null | null | Neo-adjuvant (N) | 2016-12-20 | 2017-01-03 | FEC + DOCETAXEL | N | N | 20087923 | FEC + DOCETAXEL |
| 20024891 | 20010572 | 1.63 | 71 | Adjuvant (A) | 2016-06-22 | 2016-07-04 | FEC + DOCETAXEL | 02 | N | 20087930 | FEC + DOCETAXEL |
| 20024892 | 20010572 | 1.64 | 58.4 | Adjuvant (A) | 2018-03-26 | 2018-04-08 | FEC + DOCETAXEL | 02 | N | 20087930 | FEC + DOCETAXEL |
| 20024893 | 20010572 | 1.61 | 128 | Adjuvant (A) | 2013-06-07 | 2013-06-27 | FEC + DOCETAXEL | N | N | 20087930 | FEC + DOCETAXEL |
| 20024894 | 20010572 | 1.56 | 90.2 | Adjuvant (A) | 2015-01-05 | 2015-01-20 | FEC + DOCETAXEL | N | N | 20087930 | FEC + DOCETAXEL |
| 20024895 | 20137804 | 1.65 | 53.95 | Curative (C) | 2014-01-15 | 2014-01-15 | FEC + DOCETAXEL | 02 | N | 20087941 | FEC + DOCETAXEL |
| 20024896 | 20137804 | 1.74 | 93.6 | Adjuvant (A) | null | 2013-06-14 | FEC + DOCETAXEL | N | N | 20087941 | FEC + DOCETAXEL |
| 20024897 | 20137804 | 1.61 | 91.5 | Adjuvant (A) | null | 2013-11-07 | FEC + DOCETAXEL | N | N | 20087941 | FEC + DOCETAXEL |
| 20024898 | 20010573 | 1.55 | 84 | Neo-adjuvant (N) | 2016-10-18 | 2016-10-24 | FEC 100 + DOCETAXEL | 2 | N | 20087946 | FEC + DOCETAXEL |
| 20024899 | 20010574 | 1.66 | 125.6 | Adjuvant (A) | 2016-09-18 | 2016-09-18 | FEC + DOCETAXEL | 02 | N | 20087948 | FEC + DOCETAXEL |
| 20024900 | 20010574 | 1.64 | null | Adjuvant (A) | 2017-05-19 | 2017-07-17 | FEC 100 + DOCETAXEL | 2 | null | 20087948 | FEC + DOCETAXEL |
| 20024901 | 20010574 | 1.7 | 51.5 | Adjuvant (A) | 2013-07-19 | 2013-08-02 | FEC 60 OR 75 + DOCETAXEL | 02 | null | 20087948 | FEC + DOCETAXEL |
| 20024902 | 20010575 | 1.66 | 65.1 | Adjuvant (A) | 2017-01-01 | 2017-01-01 | FEC + DOCETAXEL | 2 | N | 20087952 | FEC + DOCETAXEL |
| 20024903 | 20010575 | null | null | Adjuvant (A) | 2015-11-02 | 2015-11-24 | FEC + DOCETAXEL | N | N | 20087952 | FEC + DOCETAXEL |
| 20024904 | 20010575 | 1.65 | 73 | Adjuvant (A) | 2017-03-17 | 2017-03-22 | FEC 100 + DOCETAXEL | null | null | 20087952 | FEC + DOCETAXEL |
| 20024905 | 20010576 | 1.49 | 76.3 | Neo-adjuvant (N) | 2017-12-24 | 2018-01-27 | FEC + DOCETAXEL | N | N | 20087957 | FEC + DOCETAXEL |
| 20024906 | 20010577 | 1.68 | null | Not known (9) | 2014-09-10 | 2014-09-24 | FEC 100 + DOCETAXEL | N | null | 20087958 | FEC + DOCETAXEL |
| 20024907 | 20010577 | 1.65 | 65.5 | null | null | 2016-11-08 | FEC 100 + DOCETAXEL | null | null | 20087958 | FEC + DOCETAXEL |
| 20024908 | 20010577 | 1.62 | 87 | Adjuvant (A) | null | 2017-06-15 | FEC + DOCETAXEL | N | null | 20087958 | FEC + DOCETAXEL |
| 20024909 | 20010578 | 1.66 | 91.5 | Not known (9) | 2013-11-27 | 2013-12-06 | FEC + DOCETAXEL | 02 | null | 20087964 | FEC + DOCETAXEL |
| 20024910 | 20010578 | 1.63 | 56.1 | Adjuvant (A) | 2017-11-26 | 2017-11-26 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20087964 | FEC + DOCETAXEL |
| 20024911 | 20010578 | 1.63 | null | Adjuvant (A) | 2016-06-09 | 2016-06-23 | FEC + DOCETAXEL | N | N | 20087964 | FEC + DOCETAXEL |